Actively Recruiting
Gastric Feeding Versus Transpyloric Feeding in Infants with Severe Bronchopulmonary Dysplasia, a Crossover Study
Led by Le Bonheur Children's Hospital · Updated on 2025-02-12
25
Participants Needed
1
Research Sites
260 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Hospitalized infants with severe bronchopulmonary dysplasia (BPD) and feeding intolerance will be randomized to 2 weeks of continuous gastric feeding or continuous transpyoloric feeding. Subjects will crossover after 2 weeks and receive 4 weeks of each feeding mode. Respiratory status will be assessed to determine the optimal feeding mode for each infant.
CONDITIONS
Official Title
Gastric Feeding Versus Transpyloric Feeding in Infants with Severe Bronchopulmonary Dysplasia, a Crossover Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Born before 32 weeks of gestation
- Currently admitted to the Le Bonheur NICU
- Diagnosed with Grade 2 or 3 bronchopulmonary dysplasia (BPD) requiring positive pressure or intubation at 36 weeks postmenstrual age
- Shows signs of gastroesophageal reflux, chronic aspiration, or other feeding intolerance
You will not qualify if you...
- Known gastrointestinal anomalies
- Unable to tolerate at least 100 mL/kg/day of enteral feeding
- Has congenital anomalies likely to affect feeding techniques
- Has a surgical feeding tube in place or expected within the next 8 weeks
- Expected to be hospitalized for less than 8 weeks
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Le Bonheur Children's Hospital
Memphis, Tennessee, United States, 38103
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here